Shadi Shahriari

Ms. Shadi Shahriari

McMaster University, Hamilton, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2021 in Micromachines
Verified
Journal Article
Open access
PDF file
MDMohammadhossein Dabaghi
Mohammadhossein Dabaghi
SSShadi Shahriari
Shadi Shahriari
NSNeda Saraei
Neda Saraei
KDKevin Da
Kevin Da
ACAbiram Chandiramohan
Abiram Chandiramohan
JHJeremy Hirota
Jeremy Hirota
Polydimethylsiloxane (PDMS) is a silicone-based synthetic material used in various biomedical applications due to its properties, including transparency, flexibility, permeability to gases, and ease of use. Though PDMS facilitates and assists the fabrication of complicated geometries at micro- and nano-scales, it does not optimally interact with cells for adherence and proliferation. Various strategies have been proposed to render PDMS to enhance cell attachment. The majority of these surface modification techniques have been offered for a static cell culture system. However, dynamic cell culture systems such as organ-on-a-chip devices are demanding platforms that recapitulate a living tissue microenvironment’s complexity. In organ-on-a-chip platforms, PDMS surfaces are usually coated by extracellular matrix (ECM) proteins, which occur as a result of a physical and weak bonding between PDMS and ECM proteins, and this binding can be degraded when it is exposed to shear stresses. This work reports static and dynamic coating methods to covalently bind collagen within a PDMS-based microfluidic device using polydopamine (PDA). These coating methods were evaluated using water contact angle measurement and atomic force microscopy (AFM) to optimize coating conditions. The biocompatibility of collagen-coated PDMS devices was assessed by culturing primary human bronchial epithelial cells (HBECs) in microfluidic devices. It was shown that both PDA coating methods could be used to bind collagen, thereby improving cell adhesion (approximately three times higher) without showing any discernible difference in cell attachment between these two methods. These results suggested that such a surface modification can help coat extracellular matrix protein onto PDMS-based microfluidic devices.

29 June 2023 in Journal of Micromechanics and Microengineering
Verified
Journal Article
Open access
SSShadi Shahriari
Shadi Shahriari
Vinay PatelVinay Patel
Vinay Patel
P. Ravi SelvaganapathyP. Ravi Selvaganapathy
P. Ravi Selvaganapathy
Microfluidic devices have been conventionally fabricated using traditional photolithography or through the use of soft lithography both of which require multiple complicated steps and a clean room setup. Xurography is an alternative rapid prototyping method which has been used to fabricate microfluidic devices in less than 20–30 minutes. The method is used to pattern two-dimensional pressure-sensitive adhesives, polymer sheets, and metal films using a cutting plotter and these layers are bonded together using methods including adhesive, thermal, and solvent bonding. This review discusses the working principle of xurography along with a critical analysis of parameters affecting the patterning process, various materials patterned using xurography, and their applications. Xurography can be used in the fabrication of microfluidic devices using four main approaches: making multiple layered devices, fabrication of micromolds, making masks, and integration of electrodes into microfluidic devices. We have also briefly discussed the bonding methods for assembling the two-dimensional patterned layers. Due to its simplicity and the ability to easily integrate multiple materials, xurography is likely to grow in prominence as a method for fabrication of microfluidic devices.

1 September 2022 in Biomicrofluidics
Verified
Journal Article
Closed access
PDF file
SSShadi Shahriari
Shadi Shahriari
P. Ravi SelvaganapathyP. Ravi Selvaganapathy
P. Ravi Selvaganapathy
Hydrogels are a critical component of many microfluidic devices. They have been used in cell culture applications, biosensors, gradient generators, separation microdevices, micro-actuators, and microvalves. Various techniques have been utilized to integrate hydrogels into microfluidic devices such as flow confinement and gel photopolymerization. However, in these methods, hydrogels are typically introduced in post processing steps which add complexity, cost, and extensive fabrication steps to the integration process and can be prone to user induced variations. Here, we introduce an inexpensive method to locally integrate hydrogels into microfluidic devices during the fabrication process without the need for post-processing. In this method, porous and fibrous membranes such as electrospun membranes are used as scaffolds to hold gels and they are patterned using xurography. Hydrogels in various shapes as small as 200 μm can be patterned using this method in a scalable manner. The electrospun scaffold facilitates drying and reconstitution of these gels without loss of shape or leakage that is beneficial in a number of applications. Such reconstitution is not feasible using other hydrogel integration techniques. Therefore, this method is suitable for long time storage of hydrogels in devices which is useful in point-of-care (POC) devices. This hydrogel integration method was used to demonstrate gel electrophoretic concentration and quantification of short DNA (150 bp) with different concentrations in rehydrated agarose embedded in electrospun polycaprolactone (PCL) membrane. This can be developed further to create a POC device to quantify cell-free DNA, which is a prognostic biomarker for severe sepsis patients.

1 July 2025 in Biomicrofluidics
Verified
Journal Article
Closed access
MGMehraneh Tavakkoli Gilavan
Mehraneh Tavakkoli Gilavan
SSShadi Shahriari
Shadi Shahriari
P. Ravi SelvaganapathyP. Ravi Selvaganapathy
P. Ravi Selvaganapathy
According to the third international consensus definition (sepsis-3), sepsis is defined as life-threatening organ dysfunction resulting from an uncontrolled host response to infection. Sepsis remains a leading cause of global mortality, largely due to the difficulty of achieving a timely diagnosis. The conventional diagnostic approaches for sepsis often face limitations in speed, portability, sensitivity, and specificity, which can lead to delayed or missed diagnoses. In response, microfluidic devices have emerged as powerful tools for point-of-care precise sample handling and preparation, enabling efficient isolation and detection of sepsis-causing bacteria and biomarkers. Fabrication techniques of these microfluidic devices, ranging from photolithography to xurography, have significantly advanced and paved the way for complex designs and improved functionality. Microfluidic platforms offer various benefits in sepsis diagnosis and prognosis. They facilitate rapid and automated sample processing, enhancing turnaround times and reducing the risk of contamination. Moreover, the integration of microfluidic systems with advanced detection methods enables the simultaneous analysis of multiple biomarkers, thereby enhancing diagnostic accuracy and prognostic capabilities. This review explores the evolution of sepsis diagnosis from traditional lab based methods to the use of microfluidic technology that can facilitate point of care diagnostics and discusses emerging trends in this field.

8 March 2024 in Gels
Verified
Journal Article
Open access
PDF file
SSShadi Shahriari
Shadi Shahriari
P. Ravi SelvaganapathyP. Ravi Selvaganapathy
P. Ravi Selvaganapathy
Sepsis, a life-threatening condition resulting from a failing host response to infection, causes millions of deaths annually, necessitating rapid and simple prognostic assessments. A variety of genomic and proteomic biomarkers have been developed for sepsis. For example, it has been shown that the level of plasma cell-free DNA (cfDNA) and circulating histones increases considerably during sepsis, and they are linked with sepsis severity and mortality. Developing a diagnostic tool that is capable of assessing such diverse biomarkers is challenging as the detection methodology is quite different for each. Here, a fully integrated microfluidic device capable of detecting a genomic biomarker (cfDNA) and a proteomic biomarker (total circulating histones) using a common detection platform has been demonstrated. The microfluidic device utilizes dehydrated agarose gates loaded with pH-specific agarose to electrophoretically trap cfDNA and histones at their respective isoelectric points. It also incorporates fluorescent dyes within the device, eliminating the need for off-chip sample preparation and allowing the direct testing of plasma samples without the need for labeling DNA and histones with fluorescent dyes beforehand. Xurography, which is a low-cost and rapid method for fabrication of microfluidics, is used in all the fabrication steps. Experimental results demonstrate the effective accumulation and separation of cfDNA and histones in the agarose gates in a total processing time of 20 min, employing 10 and 30 Volts for cfDNA and histone accumulation and detection, respectively. The device can potentially be used to distinguish between the survivors and non-survivors of sepsis. The integration of the detection of both biomarkers into a single device and dye immobilization enhances its clinical utility for rapid point-of-care assessment of sepsis prognosis.